Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2023 / Honorees / Marie-José Tassignon

Marie-José Tassignon

  • Profile

About Marie-José Tassignon

Emeritus Head of the Department of Ophthalmology, University hospital and University of Antwerp, Belgium

What’s been the biggest breakthrough in ophthalmology/your specific field over the last 10 years?

The intraoperative OCT was for me a revolutionary tool to visualize the anterior interface during cataract surgery. This is still the only technology that allows better understanding of the interface that was considered for a long time to be virtual. Based on this intraoperative use of the OCT we were able to describe congenital dysgenesis type of cataract, which we called AVLID – anterior vitreo-lenticular interface dysgenesis. This technology allowed us to observe AVD – anterior vitreous detachment (in contrast to PVD – posterior vitreous detachment) in 60 percent of the cataract patients from 45 years on. It allowed us then to define a model studying the impact of Wieger's ligament on accommodation.

Is there a particular tool, technological advance, or instrument you would not have been able to live without over the past 10 years?

As above, intraoperative OCT has been of great importance in my clinical research.

Do you have any strong opinions with which the rest of the field tends to disagree?

Yes, I am convinced that the bag-in-the-lens device and implantation technique is the only IOL that allows: surgeon control centration, eradicates PCO in a high percentage compared with the traditional lens implantation, optimal alignment along the patient’s visual axis (although the optimal alignment method still needs to be improved), optimal survival of the capsular bag by keeping the patient’s LEC sequestered in the periphery of the capsular bag.

What would you like to see change in ophthalmology/your subspecialty over the next 10 years – and why?

Improvement in the possibility of ophthalmologists to be educated and/or practice more easily all over the globe. Dissemination of technology would be easier and quicker.

Do you have any personal missions for the next 10 years?

I would like to implement the continuous extended depth of focus version of the bag-in-the-lens and develop a new method to treat patients with complaints of floaters, without the need for surgical vitrectomy.

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: